Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Protein Discovery Could Lead to Development of New Antiretroviral That Prevents HIV From Entering Cells, Study Says

October 11, 2007

The discovery of a type of peptide -- short proteins that include natural and artificial compounds such as hormones and antibiotics -- could lead to the development of a new antiretroviral drug that prevents HIV from entering human cells, according to a study published in the Oct. 9 issue of Proceedings of the National Academy of Sciences, the Salt Lake Tribune reports.

Michael Kay, an assistant professor of biochemistry at the University of Utah, and colleagues found that D peptides bind to a key component of HIV called a pocket, which helps the virus enter cells. The pocket is similar in all strains of the virus and is unable to mutate without affecting the virus' ability to enter cells, Kay said. The D peptide "basically" is a "knob that will fit into that pocket and block binding particles," preventing the virus from spreading among cells, Kay said.

Manufactured peptides have the potential to be taken orally and are "much more durable than natural peptides," Kay said, adding that natural peptides "generally make poor drugs because they must be injected and are readily degraded by the body." According to the Tribune, manufactured D peptides might be able to remain in the body for longer periods of time than natural peptides. A main component of the research -- which is being funded by NIH, the University of Utah Research Foundation and the American Cancer Society -- is the "attempt to anticipate and avoid drug resistance," according to Kay.

Advertisement
Preclinical trials and advanced laboratory studies of D peptides are under way to determine how well the peptides work. If the peptides are proved safe and effective, they could suppress the spread of the virus in HIV-positive people, preserve their immune systems and prevent transmission to HIV-negative people. A drug could be tested among humans within two years, according to the Tribune. In addition, a drug using D peptides could be used as a microbicide to prevent the spread of the virus in developing countries, the Tribune reports.

Although the research is in early stages, Kay said he hopes that the discovery will lead to the development of D peptide treatments for other viruses, such as Ebola and influenza (Rosetta, Salt Lake Tribune, 10/10).

Back to other news for October 2007


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement